
Patients and associationsCanada
Sanofi and the pan-Canadian Pharmaceutical Alliance sign Letter of Intent for Sarclisa®(isatuximab), a step toward public access for newly diagnosed, transplant-ineligible multiple myeloma patients
PR Newswire Canada (Canada) · November 16, 2026, 2:15 PM
A MielomaAI está a ler a notícia e a fazer o resumo (até 1 minuto)…
Summary written by MielomaAI from the text of the news. It may contain errors: read the full news and talk to your doctor.Summary written by MielomaAI from the first sentences (the full text could not be read). It may contain errors: read the full news.
The summary could not be made right now. You can read the full news at the source.
Read the full news · source: PR Newswire Canada ↗